Use of a continuous culture fermentation system to investigate the effect of GanedenBC30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota

Anaerobe

Volumn 17, Issue 1, 2011, Pages 36-42

  Honda, Harue ^a   Gibson, Glenn R ^a   Farmer, Sean ^b   Keller, David ^b   McCartney, Anne L ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Ganeden Biotech Inc   (United States)

Author keywords

Anti microbial; Bacillus coagulans; Probiotic

Indexed keywords

GANEDENBC 30; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS COAGULANS; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CLUSTER ANALYSIS; CONTINUOUS CULTURE; CONTINUOUS FERMENTATION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; GASTROINTESTINAL TRACT; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; INTESTINE FLORA; MALE; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SPOROGENESIS; SUPPLEMENTATION;

ADULT; ANTIBIOSIS; BACILLUS; BIODIVERSITY; BIOREACTORS; CLOSTRIDIUM; COLONY COUNT, MICROBIAL; DNA FINGERPRINTING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; FEMALE; FERMENTATION; GASTROINTESTINAL TRACT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROBIAL VIABILITY; NUCLEIC ACID DENATURATION; SALMONELLA;

BACILLUS COAGULANS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 79951509963     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2010.12.006     Document Type: Article

References (39)

1. Hong H.A., Duc L.H., Cutting S.M. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 2005, 29:813-835.
2. Sanders M.E., Morelli L., Tompkins T.A. Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Compr Rev Food Sci Food Safety 2003, 2:101-110.
3. Hyronimus B., le Marrec C., Urdaci C.M. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol 1998, 85:42-50.
4. Barbosa T.M., Serra C.R., La Ragione R.M., Woodward M.J., Henriques A.O. Screening for bacillus isolates in the broiler gastrointestinal tract. Appl Environ Microbiol 2005, 71:968-978.
5. Fakhry S., Sorrentini I., Ricca E., de Felice M., Baccigalupi L. Characterization of spore forming Bacilli isolated from the human gastrointestinal tract. J Appl Microbiol 2008, 105:2178-2186.
6. Hoyles L. In vitro examination of the effect of orlistat on the ability of the faecal microbiota to utilize dietary lipids. PhD Thesis. University of Reading, UK; 2009.
7. Donskey C.J., Hoyen C.K., Das S.M., Farmer S., Dery M., Bonomo R.A. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol 2001, 33:84-88.
8. Hoa T.T., Duc L.H., Isticato R., Baccigalupi L., Ricca E., Van P.H., et al. Fate and dissemination of Bacillus subtilis spores in a murine model. Appl Environ Microbiol 2001, 67:3819-3823.
9. Tam N.K.M., Uyen N.Q., Hong H.A., Duc L.H., Hoa T.T., Serra C.R., et al. The intestinal life cycle of Bacillus subtilis and close relatives. J Bacteriol 2006, 188:2692-2700.
10. La Ragione R.M., Casula G., Cutting S.M., Woodward M.J. Bacillus subtilis spores competitively exclude Escherichia coli O78:K80 in poultry. Vet Microbiol 2001, 79:133-142.
11. La Ragione R.M., Woodward M.J. Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteriditis and Clostridium perfringens in young chickens. Vet Microbiol 2003, 94:245-256.
12. Ciprandi G., Vizzaccaro A., Cirillo I., Tosca M.A. Bacillus clausii exerts immunomodulatory activity in allergic subjects: a pilot study. Eur Ann Allergy Clin Immunol 2005, 37:129-134.
13. Huang J.-M., La Ragione R.M., Nunez A., Cutting S.M. Immunostimulatory activity of Bacillus spores. FEMS Immunol Med Microbiol 2008, 53:195-203.
14. Baron M. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med 2009, 121:114-118.
15. 30 on immunological markers. Methods Find Exp Clin Pharmacol 2010, 32:129-132.
16. Jensen G.S., Benson K.F., Carter S.G., Endres J.R. GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro. BMC Immunol 2010, 11:15-29.
17. Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med 2009, 121:119-124.
18. Dolin B.J. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol 2009, 31:655-659.
19. Honda H, Hoyles L, Gibson GR, Farmer S, Keller D, McCartney AL. Impact of GanedenBC30 (Bacillus coagulans GBI-30, 6086) on population dynamics of the human gut microbiota in a continuous culture fermentation system. Int J Probiotics Prebiotics 2011;6: in press.
20. Fooks J.L., Gibson G.R. Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. Anaerobe 2003, 9:231-242.
21. Gibson G.R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994, 77:412-420.
22. Richardson A.J., Calder A.G., Stewart C.S., Smith A. Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas chromatography. Lett Appl Microbiol 1989, 9:5-8.
23. Martín-Peláez S., Gibson G.R., Martín-Orúe S.M., Klinder A., Rastall R.A., La Ragione R.M., et al. In vitro fermentation of carbohydrates by porcine faecal inocula and their influence on Salmonella Typhimurium growth in batch culture systems. FEMS Microbiol Ecol 2008, 66:608-619.
24. Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 1993, 59:695-700.
25. Roger LC. Investigations into the biological succession of the infant faecal microbiota. PhD Thesis. University of Reading, UK; 2008.
26. Ducluzeau R., Dubos F., Raibaud P., Abrams G.D. Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract. Antimicrob Agents Chemother 1976, 9:20-25.
27. Ducluzeau R., Dubos F., Raibaud P., Abrams G.D. Production of an antibiotic substance by Bacillus licheniformis within the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother 1978, 13:97-103.
28. Osmanova HR. Investigation of the antimicrobial activity of Bacillus licheniformis 8-2AIA in relation to different growth phases. MSc Dissertation. University of Reading; 2010.
29. Daims H., Brühl A., Amann R., Schleifer K.-H., Wagner M. The domain-specific probe EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a more comprehensive probe set. Syst Appl Microbiol 1999, 22:434-444.
30. Harmsen H.J.M., Wildeboer-Veloo A.C.M., Grijpstra J., Knol J., Degener J.E., Welling G.W. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000, 66:4523-4527.
31. Manz W., Amann R., Ludwig W., Vancanneyt M., Schleifer K.-H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996, 142:1097-1106.
32. Sakari K., Ezaki Y. Open l-lactic acid fermentation of food refuse using thermophilic Bacillus coagulans and fluorescence in situ hybridization analysis of microflora. J Biosci Bioeng 2006, 101:457-463.
33. Langendijk P.S., Schut F., Jansen G.J., Raangs G.C., Kamphuis G.R., Wilkinson M.H., et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069-3075.
34. Franks A.H., Harmsen H.J.M., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336-3345.
35. Poulsen K.L., Lan F., Kristensen S.C., Hobolth P., Molin S., Krogfelt A.K. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ bybridization. Infect Immun 1994, 62:5191-5194.
36. Harmsen H.J.M., Elfferich P., Schut F., Welling G.W. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999, 11:3-12.
37. Walker A.W., Duncan S.H., McWilliam Leitch E.C., Child M.W., Flint H.J. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005, 71:3692-3700.
38. Harmsen H.J.M., Raangs G.C., He T., Degener J.E., Welling G.W. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002, 68:2982-2990.
39. Nordentoft S., Christensen H., Wegener C.H. Evaluation of a fluorescence-labelled oligonucleotide probe targeting 23S rRNA for in situ detection of Salmonella serovars in paraffin-embedded tissue sections and their rapid identification in bacterial smears. J Clin Microbiol 1997, 35:2642-2648.